Colitis in patients with breast carcinoma treated with taxane‐based chemotherapy
Colitis in patients with breast carcinoma treated with taxane‐based chemotherapy
复制标题
接受紫杉烷类化疗癌治疗的乳腺癌患者的结肠炎
作者：
Zhiyong Li;N. Ibrahim;J. Wathen;Michael Wang;Rosario P. Mante Menchu;V. Valero;R. Theriault;A. Buzdar;G. Hortobagyi
结肠炎是癌症患者基于紫杉烷的化疗相关的一种罕见但严重的胃肠道并发症。基于紫杉烷的化疗治疗的乳腺癌患者中结肠炎的发生率、临床表现和结果尚不明确。
Colitis is a rare but serious gastrointestinal complication associated with taxane‐based chemotherapy in patients with cancer. The incidence, clinical presentation, and outcome of colitis in patients with breast carcinoma treated with taxane‐based chemotherapy is not known.
DOI：
10.1093/jnci/83.4.288
发表时间：
1991-02-20
期刊：
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子：
--
作者：
RINGEL, I;HORWITZ, SB
通讯作者：
HORWITZ, SB